Thomas E. Emerson

715 total citations
24 papers, 539 citations indexed

About

Thomas E. Emerson is a scholar working on Immunology, Surgery and Molecular Biology. According to data from OpenAlex, Thomas E. Emerson has authored 24 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Surgery and 5 papers in Molecular Biology. Recurrent topics in Thomas E. Emerson's work include Immune Response and Inflammation (5 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Sepsis Diagnosis and Treatment (3 papers). Thomas E. Emerson is often cited by papers focused on Immune Response and Inflammation (5 papers), Eicosanoids and Hypertension Pharmacology (3 papers) and Sepsis Diagnosis and Treatment (3 papers). Thomas E. Emerson collaborates with scholars based in United States. Thomas E. Emerson's co-authors include Lerner B. Hinshaw, Michael A. Fournel, P. F. Iampietro, Alvin Chang, Richard B. Passey, Gary L. White, Glenn Peer, Fletcher B. Taylor, Stanley D. Kosanke and Cynthia K. Murray and has published in prestigious journals such as Clinical Infectious Diseases, The American Journal of Medicine and Journal of neurosurgery.

In The Last Decade

Thomas E. Emerson

24 papers receiving 489 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas E. Emerson United States 11 180 120 101 78 78 24 539
G. Schlag Austria 12 182 1.0× 154 1.3× 127 1.3× 81 1.0× 97 1.2× 38 567
A. M. Giovanetti Italy 10 78 0.4× 32 0.3× 59 0.6× 96 1.2× 93 1.2× 13 647
D H Van Thiel United States 18 274 1.5× 41 0.3× 209 2.1× 107 1.4× 42 0.5× 44 950
Lorenzo Labarta Spain 16 313 1.7× 101 0.8× 67 0.7× 145 1.9× 82 1.1× 33 657
Lucjan Pawlicki Poland 15 105 0.6× 114 0.9× 154 1.5× 94 1.2× 16 0.2× 67 685
A. Marocchi Italy 14 107 0.6× 27 0.2× 73 0.7× 121 1.6× 29 0.4× 35 604
Dean A. Arvan United States 13 68 0.4× 14 0.1× 162 1.6× 83 1.1× 42 0.5× 31 544
George Dikdan United States 17 220 1.2× 62 0.5× 366 3.6× 126 1.6× 55 0.7× 33 836
K. W. Rumpf Germany 15 44 0.2× 35 0.3× 110 1.1× 95 1.2× 13 0.2× 38 534
R. B. Sewell Australia 16 220 1.2× 32 0.3× 255 2.5× 236 3.0× 28 0.4× 53 1.0k

Countries citing papers authored by Thomas E. Emerson

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Emerson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Emerson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Emerson more than expected).

Fields of papers citing papers by Thomas E. Emerson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Emerson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Emerson. The network helps show where Thomas E. Emerson may publish in the future.

Co-authorship network of co-authors of Thomas E. Emerson

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Emerson. A scholar is included among the top collaborators of Thomas E. Emerson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Emerson. Thomas E. Emerson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balk, R.A., Thomas E. Emerson, François Fourrier, et al.. (1998). Therapeutic Use of Antithrombin Concentrate in Sepsis. Seminars in Thrombosis and Hemostasis. 24(2). 183–194. 22 indexed citations
2.
Hinshaw, Lerner B., Thomas E. Emerson, Fletcher B. Taylor, et al.. (1992). LETHAL STAPHYLOCOCCUS AUREUS-INDUCED SHOCK IN PRIMATES. The Journal of Trauma: Injury, Infection, and Critical Care. 33(4). 568–573. 109 indexed citations
3.
Emerson, Thomas E.. (1989). Unique features of albumin. Critical Care Medicine. 17(7). 690–694. 155 indexed citations
4.
Emerson, Thomas E., et al.. (1989). Efficacy of antithrombin III supplementation in animal models of fulminant Escherichia coli endotoxemia or bacteremia. The American Journal of Medicine. 87(3). S27–S33. 74 indexed citations
5.
Emerson, Thomas E.. (1987). Effects of Purified Fibronectin Alone and Combined with Immunoglobulin G or Antithrombin-III on Survival during Gram-negative Peritonitis or Endotoxemia in Rats. The Journal of Trauma: Injury, Infection, and Critical Care. 21(11). 1261–1266. 2 indexed citations
6.
Emerson, Thomas E., et al.. (1986). Use of a New, Low-pH Immunoglobulin G Preparation During Episodes of Bacteremia in the Rat. Clinical Infectious Diseases. 8(Supplement_4). S409–S419. 5 indexed citations
7.
Raymond, Richard M., et al.. (1985). Skeletal Muscle Insulin Unresponsiveness During Chronic Hyperdynamic Sepsis in the Dog. The Journal of Trauma: Injury, Infection, and Critical Care. 25(9). 845–855. 11 indexed citations
8.
Daugherty, Robert M., et al.. (1978). Effects of ethanol- and saline-base PGE1 on the canine cerebral circulation. Journal of neurosurgery. 48(5). 724–729. 1 indexed citations
9.
Emerson, Thomas E., et al.. (1974). Effects of hemodialysis-induced hypokalemia and hypomagnesemia on blood pressure in dogs. American Heart Journal. 88(2). 198–204. 2 indexed citations
10.
Emerson, Thomas E.. (1972). Participation of Endogenous Vasoactive Agents in the Pathogenesis of Endotoxin Shock. Advances in experimental medicine and biology. 23(0). 25–45. 4 indexed citations
11.
Emerson, Thomas E., et al.. (1970). PERIPHERAL VASCULAR EFFECTS OF CYCLOPROPANE AND HALOTHANE IN THE DOG. Journal of Pharmacology and Experimental Therapeutics. 174(1). 169–175. 5 indexed citations
12.
Hinshaw, Lerner B., et al.. (1966). EFFECTS OF THE INSECTICIDE ENDRIN ON THE CARDIOVASCULAR SYSTEM OF THE DOG. Journal of Pharmacology and Experimental Therapeutics. 153(2). 225–236. 3 indexed citations
13.
Emerson, Thomas E., et al.. (1965). Vascular effects of angiotensin and norepinephrine in the dog, cat, and monkey. American Journal of Physiology-Legacy Content. 208(2). 260–264. 12 indexed citations
14.
Emerson, Thomas E., et al.. (1965). ENDOTOXIN SHOCK IN CHRONIC SPLANCHNIC DENERVATED DOGS. The Journal of Trauma: Injury, Infection, and Critical Care. 5(6). 737–740. 9 indexed citations
15.
Emerson, Thomas E.. (1965). MECHANISMS OF HEMOCONCENTRATION IN THE DOG DURING ACUTE ENDRIN INSECTICIDE POISONING. Canadian Journal of Physiology and Pharmacology. 43(5). 793–800. 2 indexed citations
16.
Emerson, Thomas E., et al.. (1964). Renal vascular response to angiotensin and other vasoactive agents in endotoxin shock. American Journal of Physiology-Legacy Content. 207(6). 1260–1264. 5 indexed citations
17.
Emerson, Thomas E., et al.. (1964). Alteration of vascular responses to endotoxin by adrenergic blockade. American Journal of Physiology-Legacy Content. 207(1). 149–151. 10 indexed citations
18.
Hinshaw, Lerner B., et al.. (1964). Renal blood flow as influenced by changes in arterial, venous, and ureteral pressures. American Heart Journal. 68(5). 652–660. 4 indexed citations
19.
Hinshaw, Lerner B., et al.. (1963). Effect of increased venous pressure on renal hemodynamics. American Journal of Physiology-Legacy Content. 204(1). 119–123. 18 indexed citations
20.
Hinshaw, Lerner B., et al.. (1962). A comparative study of the hemodynamic actions of histamine and endotoxin. American Journal of Physiology-Legacy Content. 203(4). 600–606. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026